等待开盘 08-25 09:30:00 美东时间
0.000
0.00%
原标题:巨头们的新战场:豪赌炎症性肠病 在许多人的认知中,胃肠不适只是一件小事,吃点药、休息休息便会好转。但对于重度克罗恩病患者而言,这却是一场持续不断、难以...
2025-04-01 14:45
2024 Financial GuidanceThe company updated 2024 full-year revenue guidance to between $45.4 billion and $46.0 billion. The company is investing heavily in increasing the supply of tirzepatide and has been balancing
2024-10-30 18:48
礼来公司宣布成功完成对Morphic Holding, Inc. 的收购。Morphic是一家生物制药公司,开发用于治疗严重慢性疾病的口服整合素疗法,包括用于治...
2024-08-19 14:54
The latest announcement is out from Morphic Holding (MORF). Amidst a significan...
2024-08-17 04:31
Morphic Holding: On August 16, 2024, Company Terminated the Company’s 2018 Stoc...
2024-08-17 04:15
智通财经APP获悉,礼来(LLY.US)周一发行了50亿美元债券,为其以32亿美元收购肠胃类药物生产商Morphic Holding(MORF.US)筹集资金...
2024-08-13 09:34